Effect of statins on renal function in patients with peripheral arterial disease

Vascular and Endovascular Surgery

Volumn 42, Issue 6, 2009, Pages 620-621

  Paraskevas, Kosmas I ^a   Bessias, Nikolaos ^a   Tzorbatzoglou, John ^a   Mikhailidis, Dimitri P ^b   Andrikopoulos, Vassilios ^a  

^a RED CROSS HOSPITAL   (Greece)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTERY DISEASE; DOSE RESPONSE; DRUG EFFECT; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LETTER; MORTALITY;

DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY; PERIPHERAL VASCULAR DISEASES; TREATMENT OUTCOME;

EID: 58149093924     PISSN: 15385744     EISSN: None     Source Type: Journal    
DOI: 10.1177/1538574408326183     Document Type: Letter

References (11)

1. Samson RH The role of statin drugs in the management of the peripheral vascular patient. Vasc Endovascular Surg. 2008 ; 42: 352-366.
2. Pasqualini L., Schillaci G., Pirro M., et al. Renal dysfunction predicts long-term mortality in patients with lower extremity arterial disease. J Intern Med. 2007 ; 262: 668-677.
3. O'Hare AM, Bertenthal D., Shlipak MG, Sen S., Chren MM Impact of renal insufficiency on mortality in advanced lower extremity peripheral arterial disease. J Am Soc Nephrol. 2005 ; 16: 514-519.
4. Mlekusch W., Exner M., Sabeti S., et al. Serum creatinine predicts mortality in patients with peripheral disease: influence of diabetes and hypertension. Atherosclerosis. 2004 ; 175: 361-367.
5. Youssef F., Gupta P., Seifalian AM, Myint F., Mikhailidis DP, Hamilton G. The effect of short-term treatment with simvastatin on renal function in patients with peripheral arterial disease. Angiology. 2004 ; 55: 53-62.
6. Alnaeb ME, Youssef F., Mikhailidis DP, Hamilton G. Short-term lipid-lowering treatment with atorvastatin improves renal function but not renal blood flow indices in patients with peripheral arterial disease. Angiology. 2006 ; 57: 65-71.
7. Alnaeb ME, Alobaid N., Seifalian AM, Mikhailidis DP, Hamilton G. Statins and peripheral arterial disease: potential mechanisms and clinical benefits. Ann Vasc Surg. 2006 ; 20: 696-705.
8. Feringa HH, Karagiannis SE, Chonchol M., et al. Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or angiotensin-converting enzyme inhibitors. J Am Soc Nephrol. 2007 ; 18: 1872-1879.
9. Feringa HH, Karagiannis SE, van Waning VH, et al. The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease. J Vasc Surg. 2007 ; 45: 936-943.
10. Owens CD, Ho KJ, Kim S., et al. Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney disease classification. J Vasc Surg. 2007 ; 45: 944-952.
11. Arvela E., Soderstrom M., Alback A., Aho PS, Tikkanen I., Lepantalo M. Estimated glomerular filtration rate (eGFR) as a predictor of outcome after infrainguinal bypass in patients with critical limb ischemia. Eur J Vasc Endovasc Surg. 2008 ; 36: 77-83.